| Title |
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study
|
|---|---|
| Published in |
Journal of Neurology, June 2019
|
| DOI | 10.1007/s00415-019-09424-8 |
| Pubmed ID | |
| Authors |
Jessica Frau, Francesco Saccà, Alessio Signori, Damiano Baroncini, Giuseppe Fenu, Pietro Annovazzi, Marco Capobianco, Elisabetta Signoriello, Alice Laroni, Sara La Gioia, Arianna Sartori, Giorgia Teresa Maniscalco, Simona Bonavita, Marinella Clerico, Cinzia Valeria Russo, Antonio Gallo, Caterina Lapucci, Antonio Carotenuto, Maria Pia Sormani, Eleonora Cocco |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
| Members of the public | 1 | 33% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 17% |
| Student > Master | 7 | 13% |
| Student > Doctoral Student | 3 | 6% |
| Student > Bachelor | 3 | 6% |
| Student > Ph. D. Student | 3 | 6% |
| Other | 8 | 15% |
| Unknown | 19 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 35% |
| Neuroscience | 7 | 13% |
| Psychology | 3 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Nursing and Health Professions | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 19 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2019.
All research outputs
#15,575,425
of 23,150,406 outputs
Outputs from Journal of Neurology
#3,300
of 4,545 outputs
Outputs of similar age
#215,777
of 351,696 outputs
Outputs of similar age from Journal of Neurology
#55
of 89 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,545 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,696 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.